Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of CSNK2B monoclonal antibody, clone 26C3
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human |
| Host species | Mouse |
| Applications | ELISA,WB-Ce |
More info about CSNK2B monoclonal antibody, clone 26C3
| Brand: | Abnova |
| Reference: | MAB0817 |
| Product name: | CSNK2B monoclonal antibody, clone 26C3 |
| Product description: | Mouse monoclonal antibody raised against full length recombinant CSNK2B. |
| Clone: | 26C3 |
| Isotype: | IgG1, lambda |
| Gene id: | 1460 |
| Gene name: | CSNK2B |
| Gene alias: | CK2B|CK2N|CSK2B|G5A|MGC138222|MGC138224 |
| Gene description: | casein kinase 2, beta polypeptide |
| Immunogen: | Recombinant His fusion protein corresponding to full length human CSNK2B. |
| Form: | Liquid |
| Recommend dilutions: | Western Blot (1:2000) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In HEPES, 150 mM NaCl (50% glycerol, 0.01% BSA, 0.03% sodium azide) |
| Storage instruction: | Store at -20°C. Aliquot to avoid repeated freezing and thawing. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Mouse |
| Antigen species / target species: | Human |
| Reactivity: | Human |
| Application image: |  |
| Application image note: | Immunoblot analysis of cell lysates. Lane 1 : K-562 cell lysate. Lane 2 : MCF-7 cell lysate. Lane 3 : HL-60 cell lysate. Lane 4 : Raji cell lysate. |
| Applications: | ELISA,WB-Ce |
| Shipping condition: | Dry Ice |
| Publications: | Are we beta-ARKing up the wrong tree? Casein kinase 1 alpha provides an additional pathway for GPCR phosphorylation.Tobin AB. Trends Pharmacol Sci. 2002 Jul;23(7):337-43. |